NCT02431598View on ClinicalTrials.gov

Eovist vs. Dotarem Healthy Volunteer MRI

PHASE4CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions

Transient Severe Arterial Phase Motion

Interventions

DRUG

gadoxetate disodium

DRUG

gadoterate dimeglumine

DRUG

Saline

Trial Locations (1)

27710

Duke Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

University of California, San Diego

OTHER

collaborator

University of Wisconsin, Madison

OTHER

lead

Duke University

OTHER